| Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation H Wang, M Yu, M Ochani, CA Amella, M Tanovic, S Susarla, JH Li, ... Nature 421 (6921), 384-388, 2003 | 3880 | 2003 |
| Reversing established sepsis with antagonists of endogenous high-mobility group box 1 H Yang, M Ochani, J Li, X Qiang, M Tanovic, HE Harris, SM Susarla, ... Proceedings of the National Academy of Sciences 101 (1), 296-301, 2004 | 1454 | 2004 |
| Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis H Wang, H Liao, M Ochani, M Justiniani, X Lin, L Yang, Y Al-Abed, ... Nature medicine 10 (11), 1216-1221, 2004 | 1386 | 2004 |
| Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway L Ulloa, J Doody, J Massagué Nature 397 (6721), 710-713, 1999 | 1091 | 1999 |
| Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation L Ulloa, M Ochani, H Yang, M Tanovic, D Halperin, R Yang, CJ Czura, ... Proceedings of the National Academy of Sciences 99 (19), 12351-12356, 2002 | 775 | 2002 |
| Splenectomy inactivates the cholinergic anti-inflammatory pathway during lethal endotoxemia and polymicrobial sepsis JM Huston, M Ochani, M Rosas-Ballina, H Liao, K Ochani, VA Pavlov, ... Shock 25 (6), 65, 2006 | 762 | 2006 |
| The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation WJ De Jonge, L Ulloa British journal of pharmacology 151 (7), 915-929, 2007 | 718 | 2007 |
| Pharmacological stimulation of the cholinergic antiinflammatory pathway TR Bernik, SG Friedman, M Ochani, R DiRaimo, L Ulloa, H Yang, ... The Journal of experimental medicine 195 (6), 781-788, 2002 | 705 | 2002 |
| Dopamine mediates vagal modulation of the immune system by electroacupuncture R Torres-Rosas, G Yehia, G Peña, P Mishra, ... Nature medicine 20 (3), 291-295, 2014 | 582 | 2014 |
| The ‘cytokine profile’: a code for sepsis L Ulloa, KJ Tracey Trends in molecular medicine 11 (2), 56-63, 2005 | 546 | 2005 |
| Structural basis for the proinflammatory cytokine activity of high mobility group box 1 J Li, R Kokkola, S Tabibzadeh, R Yang, M Ochani, X Qiang, HE Harris, ... Molecular medicine 9, 37-45, 2003 | 540 | 2003 |
| The vagus nerve and the nicotinic anti-inflammatory pathway L Ulloa Nature reviews Drug discovery 4 (8), 673-684, 2005 | 537 | 2005 |
| High-mobility group box 1 (HMGB1) protein: friend and foe L Ulloa, D Messmer Cytokine & growth factor reviews 17 (3), 189-201, 2006 | 486 | 2006 |
| The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice DJ Van Westerloo, IA Giebelen, S Florquin, MJ Bruno, GJ LaRosa, L Ulloa, ... Gastroenterology 130 (6), 1822-1830, 2006 | 462 | 2006 |
| High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis R Kokkola, E Sundberg, AK Ulfgren, K Palmblad, J Li, H Wang, L Ulloa, ... Arthritis & Rheumatism 46 (10), 2598-2603, 2002 | 399 | 2002 |
| α7-cholinergic receptor mediates vagal induction of splenic norepinephrine G Vida, G Peña, EA Deitch, L Ulloa The Journal of Immunology 186 (7), 4340-4346, 2011 | 275 | 2011 |
| Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14-and TNF-dependent mechanisms G Chen, J Li, M Ochani, B Rendon-Mitchell, X Qiang, S Susarla, L Ulloa, ... Journal of leukocyte biology 76 (5), 994-1001, 2004 | 266 | 2004 |
| Hmgb-1 as a therapeutic target for infectious and inflammatory disorders LL Mantell, WR Parrish, L Ulloa Shock 25 (1), 4-11, 2006 | 215 | 2006 |
| Depletion of casein kinase II by antisense oligonucleotide prevents neuritogenesis in neuroblastoma cells. L Ulloa, J Diaz‐Nido, J Avila The EMBO journal 12 (4), 1633-1640, 1993 | 198 | 1993 |
| Recombinant HMGB1 with cytokine-stimulating activity J Li, H Wang, JM Mason, J Levine, M Yu, L Ulloa, CJ Czura, KJ Tracey, ... Journal of immunological methods 289 (1-2), 211-223, 2004 | 187 | 2004 |
